“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Saturday, August 30, 2025

Avadel Pharmaceuticals


Avadel Pharmaceuticals products


LUMRYZ (sodium oxybate extended-release oral suspension)
Indication: Once-nightly treatment for excessive daytime sleepiness (EDS) and cataplexy in narcolepsy
Status: Approved in the U.S. for adults and children aged 7 years and older

FT218 (sodium oxybate—Micropump® formulation)
Indication: Once-nightly extended-release sodium oxybate for idiopathic hypersomnia
Status: Phase III clinical development



on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)